Strada delle Scotte, 6 53100 Siena
tel 0577 233228

Sei in: InSostanza > Un aiuto subito > Centri antifumo

Centri antifumo

Centro Antifumo Zona Senese
c/o Policlinico “Santa Maria alle Scotte”
U.O. Fisiopatologia e Riabilitazione Respiratoria
Viale M. Bracci, 16 – 53100 Siena Tel. 0577.586760 – fax: 0577586196
e-mail: a.melani@ao-siena.toscana.it
Contatto Telefonico: dal lunedì al venerdì ore 8.00/14.00
Contatto Diretto presso il Servizio: dal lunedì al venerdì ore 8.00/14.00

Centro Antitabagico Integrato Zona Val d’Elsa
c/o Ser.T Colle Val d’Elsa
Via della Porta Vecchia, 21 – 53034 Colle Val d’Elsa
tel. 0577 926882- fax 0577 922107
e-mail: antitab.elsa@usl7.toscana.it
Contatto Telefonico: dal lunedì al venerdì ore 8.00/14.00
Contatto Diretto presso il Servizio: dal lunedì al venerdì ore 8.00/14.00

Centro Antifumo Zona Amiata
c/o Poliambulatorio
Via Serdini, 46 – 53021 Abbadia S. Salvatore
tel e fax 0577 782440
e-mail: sertamiata@usl7.toscana.it
Contatto Telefonico: dal lunedì al venerdì ore 8.30/12.30
Contatto Diretto presso il Servizio: dal lunedì al venerdì ore 8.30/12.30

Centro Antifumo Zona Val di Chiana Senese
c/o Ser.T. Zona Val di Chiana Senese
ex Presidio Ospedaliero, via Vesuvio 15, 53042 Chianciano Terme (SI)
Tel. 0578 713889 – 713895 Fax 0578 713898e-mail: m.paterni@usl7.toscana.it ; m.c.morelli@usl7.toscana.it
Referente/i:Dr. Massimo Paterni (medico responsabile)
Dr.ssa Maria Cristina Morelli (medico)
Contatto Telefonico:
Lun. – Ven. ore 8.00 / 13.00 – 14.00 / 18.00; tramite CUP 0577/382222
Contatto Diretto presso il Servizio:
Lun. – Ven. ore 8.00 / 13.00 (Dr.ssa M.C. Morelli o amministrazione)

Centro Antifumo “Le Scotte” Siena
Viale Bracci, 16 53100 Siena – SI
Tel. 0577/586766; Fax 0577/586196
Referente: Dr. Andrea Melani, E-mail: a.melani@ao- siena.toscana.it
Modalità di contatto: Contatto diretto o telefonico da parte dell’interessato Lun.-sab. ore 8.00/13.30

LILT(Lega italiana per la lotta contro i tumori) Siena
Strada Massetana Romana 44, 53100 Siena
Tel. 0577/285147 Fax 0577/44104
E-mail: info@legatumori_siena.it



European Drug Report 2018: Trends and Developments.

High availability of drugs across all types. Over 1 million seizures in Europe in 2016. Over 92 million adults in the EU have tried an illicit drug in their lifetime. 1.3 million people received treatment for illicit drugs. Cocaine purity at street level reached its highest level in a decade. Increase in number of cocaine seizures. Increase in cocaine residues in wastewater in 26 of 31 cities between 2015 and 2017. Rise in number of first-time admissions to specialised treatment for problems related to cocaine. Europe is an important market for drugs trafficked in from other regions. But there are worrying signs of increased drug production inside Europe. Cannabis availability and use remain high. Cannabis is involved in 77 % of drug law offences. Rapid emergence of a commercial cannabis market in parts of the Americas. Fewer new psychoactive substances reported for the first time. But there is more evidence of harm. Health harms linked to highly potent new synthetic cannabinoids and synthetic opioids prompted nine risk assessments. Synthetic cannabinoids are the most frequently seized NPS in Europe. Synthetic opioids and particularly fentanyl derivatives are increasingly detected. Fentanyl derivatives — key players in the US opioid crisis — call for concern & vigilance. NPS use and related harms are a new challenge for prison system. Prisons are a critical setting for addressing the healthcare needs of drug users. Online markets appear to be of growing importance. A recent EMCDDA–Europol study identified more than 100 darknet markets. Concerns over unlicensed benzodiazepines sold on the street and online. Increasing number of overdose deaths raises concerns. Renewed focus on the role of take-home naloxone in overdose response strategies. Read more in the European Drug Report 2018: emcdda.europa.eu/edr2018